Journey Medical Corporation (NASDAQ:DERM) Given Consensus Rating of “Hold” by Analysts

Journey Medical Corporation (NASDAQ: DERM - Get Free Report) has been assigned an average recommendation of "Hold" from the five research firms that are presently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell rating, one has given a hold rating and three have assigned a buy rating to the